low blood sugar and semaglutide & Sugar: Safety & Biomarker Context – PlexusDx Study flags low blood sugar

Top of the line service

Journal of the American Pharmacists Association: JAPhA, 64 (1), 133138

Semaglutide is FDA-approved for type 2 diabetes management (Ozempic, Rybelsus), cardiovascular risk reduction in patients with type 2 diabetes and established cardiovascular disease (Ozempic), chronic weight management in obesity or overweight with comorbidities (Wegovy), and cardiovascular risk reduction in adults with established cardiovascular disease and obesity or overweight (Wegovy)

This means it provides a sustained elevation of baseline GH rather than sharp pulses

While this type of cancer was only found in rodent studies (not in humans), people who have a personal or family history of thyroid cancer, including medullary thyroid carcinoma (MTC), or MEN2 syndrome shouldn't take GLP-1 medications like Mounjaro or Ozempic